These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 27811020)

  • 21. Low Counts of Plasmacytoid Dendritic Cells after Engraftment Are Associated with High Early Mortality after Allogeneic Stem Cell Transplantation.
    Gonçalves MV; Yamamoto M; Kimura EY; Colturato VA; de Souza MP; Mauad M; Ikoma MV; Novis Y; Rocha V; Ginani VC; Wanderley de Oliveira Felix OM; Seber A; Kerbauy FR; Hamerschlak N; Orfao A; Rodrigues CA
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1223-9. PubMed ID: 25792371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Common variants in NLRP2 and NLRP3 genes are strong prognostic factors for the outcome of HLA-identical sibling allogeneic stem cell transplantation.
    Granell M; Urbano-Ispizua A; Pons A; Aróstegui JI; Gel B; Navarro A; Jansa S; Artells R; Gaya A; Talarn C; Fernández-Avilés F; Martínez C; Rovira M; Carreras E; Rozman C; Juan M; Yagüe J; Montserrat E; Monzó M
    Blood; 2008 Nov; 112(10):4337-42. PubMed ID: 18772453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Post-Thaw Viable CD45+ Cells and Clonogenic Efficiency are Associated with Better Engraftment and Outcomes after Single Cord Blood Transplantation in Adult Patients with Malignant Diseases.
    Castillo N; García-Cadenas I; Barba P; Martino R; Azqueta C; Ferrà C; Canals C; Sierra J; Valcárcel D; Querol S
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2167-2172. PubMed ID: 26319094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased nonrelapse mortality after unrelated cord blood transplantation for acute myeloid leukemia using reduced-intensity conditioning: a prospective phase II multicenter trial.
    Rio B; Chevret S; Vigouroux S; Chevallier P; Fürst S; Sirvent A; Bay JO; Socié G; Ceballos P; Huynh A; Cornillon J; Françoise S; Legrand F; Yakoub-Agha I; Michel G; Maillard N; Margueritte G; Maury S; Uzunov M; Bulabois CE; Michallet M; Clement L; Dauriac C; Bilger K; Gluckman E; Ruggeri A; Buzyn A; Nguyen S; Simon T; Milpied N; Rocha V;
    Biol Blood Marrow Transplant; 2015 Mar; 21(3):445-53. PubMed ID: 25460357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of the Hematopoietic Cell Transplantation Comorbidity Index and the European Group for Blood and Marrow Transplantation score allows a better stratification of high-risk patients undergoing reduced-toxicity allogeneic hematopoietic cell transplantation.
    Barba P; Martino R; Pérez-Simón JA; Fernández-Avilés F; Castillo N; Piñana JL; López-Anglada L; Rovira M; Bosch F; Carreras E; Corral LL; Sierra J; Valcárcel D
    Biol Blood Marrow Transplant; 2014 Jan; 20(1):66-72. PubMed ID: 24141006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective multicenter study of single-unit cord blood transplantation with myeloablative conditioning for adult patients with high-risk hematologic malignancies.
    Mori T; Tanaka M; Kobayashi T; Ohashi K; Fujisawa S; Yokota A; Fujita H; Nakaseko C; Sakura T; Nannya Y; Takahashi S; Kanamori H; Kanda Y; Sakamaki H; Okamoto S;
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):486-91. PubMed ID: 23253560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparison of intensified myeloablative conditioning regime without antithymocytic globulin (ATG) with myeloablative conditioning regime for single-unit unrelated umbilical cord blood transplantation in hematological malignancies].
    Sun ZM; Liu HL; Wu Y; Geng LQ; Zheng CC; Tang BL; Zhu XY; Tong J; Wang XB; Ding KY; Wan X; Zhang L; Yao W; Zhang XH; Han YS; Yang HZ; Liu X; Zhu WW; Wu JS; Wang ZY
    Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(28):2214-9. PubMed ID: 27480651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Human Leukocyte Antigen Allele Mismatch in Unrelated Bone Marrow Transplantation with Reduced-Intensity Conditioning Regimen.
    Yokoyama H; Kanda J; Fuji S; Kim SW; Fukuda T; Najima Y; Ohno H; Uchida N; Ueda Y; Eto T; Iwato K; Kobayashi H; Ozawa Y; Kondo T; Ichinohe T; Atsuta Y; Kanda Y;
    Biol Blood Marrow Transplant; 2017 Feb; 23(2):300-309. PubMed ID: 27845190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between Nondominant Unit Total Nucleated Cell Dose and Engraftment in Myeloablative Double-Unit Cord Blood Transplantation.
    Purtill D; Stevens CE; Lubin M; Ponce D; Hanash A; Giralt S; Scaradavou A; Young JW; Barker JN
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1981-4. PubMed ID: 26211983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of HLA in cord blood transplantation outcomes.
    Ruggeri A; Paviglianiti A; Gluckman E; Rocha V
    HLA; 2016 Jun; 87(6):413-21. PubMed ID: 27060588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Better allele-level matching improves transplant-related mortality after double cord blood transplantation.
    Oran B; Cao K; Saliba RM; Rezvani K; de Lima M; Ahmed S; Hosing CM; Popat UR; Carmazzi Y; Kebriaei P; Nieto Y; Rondon G; Willis D; Shah N; Parmar S; Olson A; Moore B; Marin D; Mehta R; Fernández-Viña M; Champlin RE; Shpall EJ
    Haematologica; 2015 Oct; 100(10):1361-70. PubMed ID: 26250579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epitope Mismatch at HLA-DRB1 Associates with Reduced Relapse Risk in Cord Blood Transplantation for Standard-Risk Hematologic Malignancy.
    Morita-Fujita M; Shindo T; Iemura T; Arai Y; Kanda J; Okada K; Ueda Y; Yoshiyuki O; Anzai N; Mori T; Ishikawa T; Otsuka Y; Yonezawa A; Yuhi N; Imada K; Oba A; Itoh M; Okamoto Y; Kitano T; Ikeda T; Kotani S; Akasaka T; Yago K; Watanabe M; Nohgawa M; Tsuji M; Takeoka T; Yamamoto R; Arima N; Yoshinaga N; Hishizawa M; Yamashita K; Kondo T; Takaori-Kondo A;
    Transplant Cell Ther; 2023 Jun; 29(6):347.e1-347.e11. PubMed ID: 36889508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Impact of High-resolution HLA-A, HLA-B, HLA-C, and HLA-DRB1 on Transplant-related Outcomes in Single-unit Umbilical Cord Blood Transplantation in Pediatric Patients.
    Armstrong AE; Smyth E; Helenowski IB; Tse WT; Duerst RE; Schneiderman J; Kletzel M; Chaudhury S
    J Pediatr Hematol Oncol; 2017 Jan; 39(1):26-32. PubMed ID: 27820121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of ABO blood group incompatibility on the outcome of single-unit cord blood transplantation after myeloablative conditioning.
    Konuma T; Kato S; Ooi J; Oiwa-Monna M; Ebihara Y; Mochizuki S; Yuji K; Ohno N; Kawamata T; Jo N; Yokoyama K; Uchimaru K; Tojo A; Takahashi S
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):577-81. PubMed ID: 24368297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Allele-Level HLA Mismatch on Outcomes in Recipients of Double Umbilical Cord Blood Transplantation.
    Brunstein CG; Petersdorf EW; DeFor TE; Noreen H; Maurer D; MacMillan ML; Ustun C; Verneris MR; Miller JS; Blazar BR; McGlave PB; Weisdorf DJ; Wagner JE
    Biol Blood Marrow Transplant; 2016 Mar; 22(3):487-92. PubMed ID: 26431630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Comparison of the Myeloablative Conditioning Regimen Fludarabine/Busulfan with Cyclophosphamide/Total Body Irradiation, for Allogeneic Stem Cell Transplantation in the Modern Era: A Cohort Analysis.
    Gooptu M; Kim HT; Ho VT; Alyea EP; Koreth J; Armand P; Ritz J; Nikiforow S; Glotzbecker BE; Nageshwar P; Soiffer RJ; Antin JH; Cutler CS
    Biol Blood Marrow Transplant; 2018 Aug; 24(8):1733-1740. PubMed ID: 29555313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of unrelated cord blood transplantation and HLA-mismatched unrelated bone marrow transplantation for adults with leukemia.
    Atsuta Y; Morishima Y; Suzuki R; Nagamura-Inoue T; Taniguchi S; Takahashi S; Kai S; Sakamaki H; Kouzai Y; Kobayashi N; Fukuda T; Azuma H; Takanashi M; Mori T; Tsuchida M; Kawase T; Kawa K; Kodera Y; Kato S;
    Biol Blood Marrow Transplant; 2012 May; 18(5):780-7. PubMed ID: 22008851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single infusion of donor mononuclear early apoptotic cells as prophylaxis for graft-versus-host disease in myeloablative HLA-matched allogeneic bone marrow transplantation: a phase I/IIa clinical trial.
    Mevorach D; Zuckerman T; Reiner I; Shimoni A; Samuel S; Nagler A; Rowe JM; Or R
    Biol Blood Marrow Transplant; 2014 Jan; 20(1):58-65. PubMed ID: 24140121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human leukocyte antigen supertype matching after myeloablative hematopoietic cell transplantation with 7/8 matched unrelated donor allografts: a report from the Center for International Blood and Marrow Transplant Research.
    Lazaryan A; Wang T; Spellman SR; Wang HL; Pidala J; Nishihori T; Askar M; Olsson R; Oudshoorn M; Abdel-Azim H; Yong A; Gandhi M; Dandoy C; Savani B; Hale G; Page K; Bitan M; Reshef R; Drobyski W; Marsh SG; Schultz K; Müller CR; Fernandez-Viña MA; Verneris MR; Horowitz MM; Arora M; Weisdorf DJ; Lee SJ
    Haematologica; 2016 Oct; 101(10):1267-1274. PubMed ID: 27247320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of anti-HLA antibodies on unrelated cord blood transplantations.
    Takanashi M; Atsuta Y; Fujiwara K; Kodo H; Kai S; Sato H; Kohsaki M; Azuma H; Tanaka H; Ogawa A; Nakajima K; Kato S
    Blood; 2010 Oct; 116(15):2839-46. PubMed ID: 20628152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.